{"id":"W2803616070","doi":"10.3390/cancers10060160","title":"A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Cancers","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"Gemcitabine; Medicine; Adenocarcinoma; Internal medicine; Oncology; Pancreatic ductal adenocarcinoma; Pancreatic cancer; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008168135,0.001270876,0.001870238,0.0003853462,0.0003361862,0.0008033075,0.0006042295,0.0008837028,0.002172558],"category_scores_gemma":[0.0004087669,0.0006672856,0.001122069,0.0003994927,0.0006480205,0.00066698,0.0003281616,0.002800418,0.0004643055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006275717,"about_ca_system_score_gemma":0.001124966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006518268,"about_ca_topic_score_gemma":0.001689945,"domain_scores_codex":[0.9997688,0.00008790717,0.00001261457,0.00005330192,0.00002693023,0.00005043243],"domain_scores_gemma":[0.9996887,0.00004488433,0.0000505955,0.00003189646,0.00002289304,0.0001609128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5350763,0.1906593,0.006802289,0.001772185,0.002111535,0.0004658862,0.0005276907,0.005489177,0.1099154,0.0004961998,0.003435373,0.1432486],"study_design_scores_gemma":[0.2805083,0.699663,0.007599203,0.00003526544,0.0004955482,0.0002452662,0.00007576958,0.00129911,0.006060061,0.0001594324,0.003831524,0.00002741265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990493,0.002386694,0.0007667762,0.0002484294,0.0001262152,0.003753825,0.000478137,0.00008455627,0.001662445],"genre_scores_gemma":[0.9876023,0.002866528,0.001632285,0.0005177612,0.0001133958,0.003209931,0.001249609,0.00002448527,0.002783623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002172558,"threshold_uncertainty_score":0.007267952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01995997718678652,"score_gpt":0.3362774205512779,"score_spread":0.3163174433644914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}